Gold

Gold
Gold

DEXE price crashes 80% in 24 hours as alleged team sell-off sparks panic

DeXe (DEXE) has suffered one of the sharpest declines in the cryptocurrency market this year after its price plunged more than 80% on Wednesday. The dramatic sell-off erased almost all of the gains from the token’s recent rally and left traders scrambling to understand what triggered the collapse. While the broader crypto market remained relatively

Read More
Gold

Magnificent 7 face the ultimate test as Q2 earnings loom

Investors have largely shifted their attention away from the Magnificent 7 companies as enthusiasm has moved toward semiconductor stocks and the broader artificial intelligence trade.  The Roundhill Magnificent 7 ETF (MAGS) has gained just 0.68% this year, significantly underperforming the S&P 500 and Nasdaq 100 indices.  With earnings from the biggest names in technology approaching,

Read More
Gold

GE Vernova beats revenue estimates, raises 2026 outlook: why is the stock falling?

GE Vernova GEV shares fell about 4% in premarket trading on Wednesday after the energy equipment maker narrowly missed Wall Street’s profit expectations. The company also warned that global tariffs could increase its costs by as much as $200 million next year, overshadowing stronger revenue growth and another increase in its full-year outlook. The company

Read More
Gold

AMD to invest up to $5B in Anthropic under AI chip supply deal: report

Advanced Micro Devices Inc. (AMD) and Anthropic have agreed to a deal covering tens of billions of dollars’ worth of artificial intelligence servers, according to a Wall Street Journal report, in a move that could strengthen AMD’s position against Nvidia while expanding Anthropic’s computing capacity. Under the reported agreement, Anthropic will purchase up to 2

Read More
Gold

Nasdaq slips as investors await Alphabet, Tesla earnings, chip stocks fall

US stocks opened lower on Wednesday as weakness in semiconductor stocks and higher oil prices weighed on investor sentiment ahead of a crucial day of corporate earnings led by Alphabet, Tesla and other major technology companies. The Dow Jones Industrial Average gained 78 points, or 0.15%. The S&P 500 declined 0.12%, while the Nasdaq Composite

Read More
Gold

Pi Network price forecast: Will Protocol v25 boost overcome token unlock pressure?

Pi Network has staged a notable recovery after falling to a fresh all-time low earlier this month, but the next phase of its price action may prove far more difficult. At the time of writing, PI is trading at $0.09119, down 1.9% over the past 24 hours but still 10.7% higher over the last seven

Read More
Gold

HyroTrader named Best Crypto Prop Firm at Web3 Awards

HyroTrader, a crypto prop firm headquartered in Prague, has been named Best Prop Trading Firm at the CoinGape Web3 Innovation Awards 2026. The recognition rewards the company’s exchange-connected funding model for digital asset traders and arrives as demand for funded trading accounts continues to climb across the crypto industry. The CoinGape Web3 Innovation Awards honor

Read More
Gold

Oklo stock jumps as firm joins $200M US AI nuclear power initiative

Oklo Inc. (OKLO) shares moved higher on Wednesday after a report said the advanced nuclear reactor developer is joining a Trump administration-led initiative designed to accelerate the development of new power plants to support the rapid expansion of artificial intelligence data centers. According to a Bloomberg report citing a document it reviewed, Oklo and X-Energy

Read More
Gold

Rocket Lab stock analysis: why it’s rising and what comes next

Rocket Lab’s stock price jumped more than 3%  after the company secured a major contract from the U.S. government. RKLB climbed to $72.15, about 12% above its lowest level this month. The key question now is whether this rebound marks the start of a sustained rally or is simply another dead-cat bounce. Rocket Lab wins

Read More
Gold

Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims

Novo Nordisk has filed a lawsuit against Eli Lilly (LLY) in a US federal court, accusing its rival of running false and misleading advertising campaigns for its blockbuster diabetes and weight-loss drugs. The lawsuit, filed Tuesday in the US District Court for the District of New Jersey, alleges that Eli Lilly and Lilly USA violated

Read More